Author:
Yang Yanli,Jiang Hui,Wang Chuhan,Jiang Nan,Wu Chanyuan,Zhang Shangzhu,Jiang Wei,Peng Jinmin,Weng Li,Zhao Jiuliang,Wang Qian,Li Mengtao,Du Bin,Zhao Yan,Zeng Xiaofeng
Abstract
Objective: To identify factors associated with mortality in SLE patients who were hospitalized for pulmonary infections (PIs).Methods: This single-center retrospective study analyzed the characteristics and risk factors for mortality in 95 SLE patients hospitalized for PIs.Results: Ninety-five SLE patients had 97 episodes of hospitalization for PIs, and 33 of these episodes (34.02%) led to death. Death from PI was associated with a higher neutrophil count (6.30 vs. 4.201 × 109/L, p < 0.01), immunoglobulin G (6.20 vs. 9.82 g/L, p = 0.01), serum creatinine (126.00 vs. 73.00 μmol/L, p = 0.01), proteinuria (2.99 vs. 0.54 g/day, p < 0.01), cardiopulmonary involvement (57.58 vs. 34.38%, p < 0.05), SLE disease activity index (SLEDAI; 11.00 vs. 6.00, p < 0.05), and opportunistic infections (78.79 vs. 45.31%, p < 0.05). Demographic characteristics, antibody/complements, bacterial infection, and primary treatment before infection (including corticosteroid and immunosuppressants) had no effect. Multivariate analysis indicated cardiopulmonary involvement (HR: 2.077; 95%CI: 1.022–4.220; p = 0.043) and opportunistic infection (HR: 2.572; 95%CI: 1.104–5.993; p = 0.029) were independent risk factors for mortality. High-dose steroid pulse therapy (HR: 0.982; 95%CI: 0.410–2.350; p = 0.982) and first-line immunosuppressant therapy (HR: 1.635; 95%CI: 0.755–3.542, p = 0.212) had no effect on mortality.Conclusion: Cardiopulmonary involvement and opportunistic infection were independent risk factors for mortality for SLE patients hospitalized for PIs. Use of high-dose pulse steroids and or immunosuppressants before hospitalization had no significant effects.
Reference24 articles.
1. Lupus in the far east: a modern epidemic;Li;Int J Rheum Dis.,2017
2. Severe infections in systemic lupus erythematosus: disease pattern and predictors of infection-related mortality;Teh CL Wan;Clin Rheumatol.,2018
3. Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies;Yurkovich;Arthritis Care Res (Hoboken).,2014
4. Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls;Bultink;Rheumatology,2020
5. JR, Lum RF, Nititham J, Taylor K, et al. Clinical and genetic risk factors for pneumonia in systemic lupus erythematosus;Kinder;Arthritis Rheum.,2007
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献